Outsourcing Insights From The President Of A Virtual Drug Discovery Company

By Ed Miseta, Chief Editor, Clinical Leader

Carolyn Green, is the President and Director for Atreaon, Inc., a privately held biopharmaceutical company developing a novel engineered protein called Atsttrin, for the treatment of inflammatory diseases such as rheumatoid arthritis. Green took the time to share her perceptions on working with CROs. She answers questions such as:

    What are the benefits to outsourcing?

    Describe a situation where you regretted outsourcing?

    What is the biggest negative perception CROs should work to overcome?